Table 2.
Clinical events and incidence rates according to the variable resistant hypertension definition
| aTRHprior (N = 206) | Control (N = 1812) | P‐value * | aTRHupdated (N = 276) | Control (N = 1735) | P‐value * | |
|---|---|---|---|---|---|---|
| HF hospitalization | 5 (5.2) | 9 (1.2) | .043 | 6 (4.6) | 8 (1.1) | .065 |
| Stroke (non‐fatal) | 3 (3.1) | 7 (0.9) | .229 | 3 (2.3) | 7 (0.9) | .325 |
| MI (non‐fatal) | 2 (2.1) | 4 (0.5) | .296 | 2 (1.5) | 4 (0.5) | .373 |
| Renal event | 34 (35.0) | 130 (16.8) | <.001 | 42 (32.3) | 122 (16.5) | .001 |
| Non‐fatal CVE | 10 (10.3) | 20 (2.6) | .020 | 11 (8.5) | 19 (2.6) | .010 |
| CV death | 1 (1.0) | 2 (0.3) | .461 | 1 (0.8) | 2 (0.3) | .530 |
| MACE | 11 (11.3) | 22 (2.8) | .007 | 12 (9.2) | 21 (2.8) | .019 |
Described as number of events (incidence rate, per 1000 patient‐years of follow‐up).
Abbreviations: CV, cardiovascular; CVE, cardiovascular event; HF, heart failure; MI, myocardial infarction. Other abbreviations are defined in Table 1.
*
Comparison was performed for incidence rate of the event.